These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 23212716)

  • 1. Weighty matters: balancing weight gain with cardiovascular risk among patients with type 1 diabetes mellitus on intensive insulin therapy.
    Fox CS
    Circulation; 2013 Jan; 127(2):157-9. PubMed ID: 23212716
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) study.
    Purnell JQ; Zinman B; Brunzell JD;
    Circulation; 2013 Jan; 127(2):180-7. PubMed ID: 23212717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial.
    Schaumberg DA; Glynn RJ; Jenkins AJ; Lyons TJ; Rifai N; Manson JE; Ridker PM; Nathan DM
    Circulation; 2005 May; 111(19):2446-53. PubMed ID: 15867184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance is associated with microangiopathy in type 1 diabetic patients treated with intensive insulin therapy from the onset of disease.
    Uruska A; Araszkiewicz A; Zozulinska-Ziolkiewicz D; Uruski P; Wierusz-Wysocka B
    Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):478-84. PubMed ID: 20373280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association.
    de Ferranti SD; de Boer IH; Fonseca V; Fox CS; Golden SH; Lavie CJ; Magge SN; Marx N; McGuire DK; Orchard TJ; Zinman B; Eckel RH
    Diabetes Care; 2014 Oct; 37(10):2843-63. PubMed ID: 25114297
    [No Abstract]   [Full Text] [Related]  

  • 6. Insulin-associated weight gain in diabetes--causes, effects and coping strategies.
    Russell-Jones D; Khan R
    Diabetes Obes Metab; 2007 Nov; 9(6):799-812. PubMed ID: 17924864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evidence based therapy with insulin in diabetic patients].
    Jermendy G
    Orv Hetil; 2005 Feb; 146(8):341-52. PubMed ID: 15803885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence of autoimmune diseases and microangiopathy in children with diabetes type 1 over the years 2000-2010].
    Głowińska-Olszewska B; Ordowska U; Golonko M; Tobiaszewska M; Florys B; Jabłońska J; Otocka A; Łuczyński W; Zasim A; Jakubowska E; Michalak J; Bossowski A
    Pediatr Endocrinol Diabetes Metab; 2013; 19(2):51-7. PubMed ID: 25612636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Insulin-substitute therapy in diabetes mellitus].
    Genes SG
    Ter Arkh; 1977; 49(12):126-31. PubMed ID: 341400
    [No Abstract]   [Full Text] [Related]  

  • 10. [Application and practice of intensive insulin therapy].
    Kishikawa H; Soejima H; Tamama Y; Araki E; Shichiri M
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():297-303. PubMed ID: 12387009
    [No Abstract]   [Full Text] [Related]  

  • 11. Deleterious effects of increased body weight associated with intensive insulin therapy for type 1 diabetes: increased blood pressure and worsened lipid profile partially negate improvements in life expectancy.
    Palmer AJ; Roze S; Valentine WJ; Minshall ME; Lammert M; Nicklasson L; Spinas GA
    Curr Med Res Opin; 2004 Aug; 20 Suppl 1():S67-73. PubMed ID: 15324518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive insulin therapy can delay long-term complications of diabetes, study shows.
    Am J Hosp Pharm; 1994 Jan; 51(1):13. PubMed ID: 8135256
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes in the lipoprotein profile in children with insulin treated type 1 diabetes mellitus].
    Schottmann B; Bergmann S; Jaross W; Michaelis D
    Z Med Lab Diagn; 1989; 30(1):76-7. PubMed ID: 2655330
    [No Abstract]   [Full Text] [Related]  

  • 14. The underuse of insulin therapy in North America.
    Riddle MC
    Diabetes Metab Res Rev; 2002; 18 Suppl 3():S42-9. PubMed ID: 12324985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular Complications of Diabetes.
    Beckman JA; Creager MA
    Circ Res; 2016 May; 118(11):1771-85. PubMed ID: 27230641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensified insulin therapy--is there anything left to argue?
    Amiel SA
    Diabet Med; 1997 Nov; 14(11):909-10. PubMed ID: 9400913
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diabeton in the treatment of stage I nephroangiopathy in insulin-dependent diabetes mellitus].
    Kashirina EP; Bryzgalina SM; Balabolkin MI
    Sov Med; 1991; (1):68-9. PubMed ID: 1862390
    [No Abstract]   [Full Text] [Related]  

  • 18. Carotid intima-media thickness in type 1 diabetes mellitus.
    Köz C
    Anadolu Kardiyol Derg; 2010 Feb; 10(1):59-60. PubMed ID: 20150007
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of insulin delivery devices in diabetes care.
    Garg SK
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S1-3. PubMed ID: 20515296
    [No Abstract]   [Full Text] [Related]  

  • 20. Pregnancy and complicated diabetes.
    Pearson JF
    Br J Hosp Med; 1993 May 19-Jun 1; 49(10):739-42. PubMed ID: 8324597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.